Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Офтальмология / Английские материалы / Visual Fields Examination and Interpretation_Walsh_2011

.pdf
Скачиваний:
2
Добавлен:
28.03.2026
Размер:
15.35 Mб
Скачать

186 Visual Fields

optic disc pallor, often with a wedge-shaped area of temporal excavation. There is mild generalized dyschromatopsia.35-40

Figure 5-9 shows wedge shaped optic atrophy commonly seen in patients with DOA.

Visual field findings include:

1.

Central scotoma. This involves the central 5° to 20° surrounding fixation.

 

Central scotoma usually indicates damage to the macular retinal ganglion cells

,

RGCs or to the papillomacular nerve fibers at or within the optic nerve. If the

 

scotoma incorporates the blind spot, the optic nerve is certainly involved.

2.

Paracentral scotoma. This involves defects within 20° of the fovea.

3.

Cecocentral scotoma. This defect extends from the physiologic blind spot

 

through and into the point of fixation. Although a central scotoma may also

A

B

Figure 5-9. Right and left eyes in a patient with dominant optic atrophy. Fundus photographs show the characteristic wedge-shaped optic atrophy seen on the temporal side of both optic discs. 5-9 A – Right eye, 5-9-B- Left eye.

Inherited or Congenital Optic Nerve Diseases

187

encompass the blind spot, a cecocentral scotoma is smaller and typically dumbbell shaped.36,39,40

Bilateral visual field central depression in a patient with DOA is shown in Figure 5-10. In general, visual prognosis is good.

The nuclear gene OPA1 located on chromosome 3 was identified in 2000 as the cause of DOA. In addition to OPA1, there are OPA4 and other OPA mutations,

,

A

Figure 5-10. Bilateral central depression, in patient with dominant optic atrophy. (Right eye)

188 Visual Fields

,

B

Figure 5-10. (Continued) (Left eye)

which have been mapped to the 3q and 18q regions, respectively. All these genes are responsible for mitochondrial structural proteins.42-45

In DOA, there is also an increased occurrence of associated sensorineural hearing loss such that these patients should be advised to undergo audiology testing. As in LHON, many agents have been tried as possible treatment options, and none were found to be effective. It remains unclear as to the role of environmental factors. These patients should be offered genetic counseling.36,39,46

,

Inherited or Congenital Optic Nerve Diseases

189

5-3-3 Recessive Optic Atrophy. This autosomal recessive somatic condition is the most uncommon form of inherited optic nerve disease. Unlike LHON and DOA, ROA is usually discovered in the first 3 to 4 years of life. It often presents as severe visual impairment, frequently associated with searching nystagmus. Visual acuity ranges between no light perception (NLP) to 20/400. There is diffuse optic disc atrophy, sometimes with attenuation of the retinal arterioles, similar to that seen in tapetoretinal degenerations. Hence, the differential diagnosis of ROA is more akin to that of retinal dystrophies than to other hereditary optic neuropathies. Electroretinography plays an important role in differentiating ROA from tapetoretinal degeneration, retinitis pigmentosa, or Leber’s congenital amaurosis, in that it is normal in ROA and severely impaired in the retinal degenerations.

The gene/chromosome for ROA remains to be identified. Not surprisingly there are several reports of consanguinity associated with this autosomal recessive condition.47-50

REFERENCES

1.Lambert SR, Hoyt CS, Narahara MH. Optic nerve hypoplasia. Surv Ophthalmol. 1987;32:1–9.

2.Brodsky MC. Congenital optic disc anomalies. Surv Ophthalmol. 1994;39:89–112.

3.Alvarez E, Wakakura M, Khan Z, et al. The disc-macula distance to disc diameter ratio: a new test for confirming optic nerve hypoplasia in young children J Pediatr Ophthalmol Strab. 1988;25:151–154.

4.Petersen RA, Walton DS. Optic nerve hypoplasia with good visual acuity and visual field defects: a study of children of diabetic mothers. Arch Ophthalmol. 1977;97: 254–258.

5.Williams J, Brodsky MC, Griebel M, et al. Septo-optic dysplasia: the clinical insignificance of an absent septum pellucidum. Dev Med Child Neurol. 1993;35:490–501.

6.Garcia-Filion P, Epport K, Nelson M, et al. Neuroradiographic, endocrinologic, and ophthalmic correlates of adverse developmental outcomes in children with optic nerve hypoplasia: a prospective study. Pediatrics. 2008;121:653–659.

7.Buchanan TA, Hoyt WF. Temporal visual field defects associated with nasal hypoplasia of the optic disc. Br J Ophthalmol. 1981;65:636–640.

8.Brodsky MC, Schroeder GT, Ford R. Superior segmental optic nerve hypoplasia in identical twins. J Clin Neuroophthalmol. 1993;13:152–154.

9.Borchert M, Garcia-Filion P. The syndrome of optic nerve hypoplasia. Curr Neurol Neurosci Rep. 2008;8:395–403.

10.Maumenee IH, Mitchell TN. Colobomatous malformations of the eye. Trans Am Ophthalmol Soc. 1990;88:123–135.

11.Irvine AR, Crawford JB, Sullivan JH. The pathogenesis of retinal detachment with morning glory disc and optic pit. Trans Am Ophthalmol Soc. 1986;84:280–292.

12.Brown GC, Shields JA, Goldberg RE. Congenital pits of the optic nerve head, II: clinical studies in humans. Ophthalmology. 1980;87:51–65.

13.Postel EA, Pulido JS, McNamara JA, et al. The etiology and treatment of macular detachment associated with optic nerve pits and related anomalies. Trans Am Ophthalmol Soc. 1998;96:73–93.

14.Graham MV and Wakefield GJ. Bitemporal visual field defects associated with anomalies of the optic discs. Br J Ophthalmol. 1973;57:307–314.

 

190

Visual Fields

 

 

 

15.

Rosenberg MA, Savino PJ, Glaser JS. A clinical analysis

of pseudopapilledema,

 

 

I: population, laterality, acuity, refractive error, ophthtalmoscopy characteristics, and

 

 

coincident disease. Arch Ophthalmol. 1979;97:65–70.

 

 

 

16.

Friedman AH, Gartner S, Modi SS. Drusen of the optic disc. A retrospective study in

 

 

cadaver eyes. Br J Ophthalmol. 1975;59:413–421.

 

 

 

17.

Kurz-Levin MM, Landau K. A comparison of imaging techniques for diagnosing drusen

 

 

of the optic nerve head. Arch Ophthalmol. 1999;117:1045–1049.

 

 

18.

Sanders TE, Gay AJ, Newman M. Drüsen of the optic disc-hemorrhagic complications.

 

19.

Trans Am Ophthalmol Soc. 1970;68:186–218.

 

 

,

Savino PJ, Glaser JS, Rosenberg MA. A clinical analysis of pseudopapilledema. II. Visual

 

 

field defects. Arch Ophthalmol. 1979;97:71–75.

 

 

 

20.

Apple DJ, Rabb MF, Walsh PM. Congenital anomalies of the optic disc. Surv Ophthalmol

 

 

1982;27:3–41.

 

 

 

21.

Sanders M. Congenital abnormalities of the optic nerve

and

related forebrain.

 

 

Br J Ophthalmol. 1984;68:511–512.

 

 

 

22.

Dorrell D. The tilted disc. Br J Ophthalmol. 1978;62:16–20.

 

 

 

23.

Berry H. Bitemporal depression of the visual field due

to

an ocular cause.

 

 

Br J Ophthalmol. 1963;47:441–444.

 

 

24.Carelli V. Leber’s hereditary optic neuropathy. In: Schapira AHV, Di Mauro S, eds. Mitochondrial Disorders in Neurology. 2nd ed. Boston: Butterworth-Heinemann; 2002;115–142.

25.Sadun AA. Metabolic optic neuropathies. Semin Ophthalmol. 2002;17:29–32.

26.Wallace DC, Singh G, Lott MT, et al. Mitochondrial DNA mutation associated with Leber’s hereditary optic neuropathy. Science. 1988;242:1427–1430.

27.Chalmers RM, Schapira AHV. Clinical, biochemical and molecular genetic features of Leber’s hereditary optic neuropathy. Biochem Biophys Acta. 1999;1410:147–158.

28.Carelli V, Ross-Cisneros FN, Sadun AA. Optic nerve degeneration and mitochondrial dysfunction: genetic and acquired optic neuropathies. Neurochem Int. 2002;40: 573–584.

29.Carelli V, Ross-Cisneros F, Sadun A. Mitochondrial dysfunction as a cause of optic neuropathies. Prog Retinal Eye Res. 2004;23:53–89.

30.Sadun AA, Carelli V, Salomao SR, et al. Extensive investigation of large Brazilian pedigree of Italian ancestry (SOA-BR) with 117788/haplogroup J Leber’s hereditary optic neuropathy (LHON). Am J Ophthalmol. 2003;136:231–238.

31.Smith JL, Hoyt WF, Susac JO. Ocular fundus in acute Leber optic neuropathy. Arch Ophthalmol. 1973;90:349–354.

32.Nikoskelainen EK. Clinical picture of LHON. Clin Neurosci. 1994;2:115–120.

33.Riordan-Eva P, Sanders MD, Govan GG, et al. The clinical features of Leber’s hereditary optic neuropathy defined by the presence of pathogenic mitochondrial DNA mutation. Brain. 1995;118:319–337.

34.Barboni P, Savini G, Valentino ML, et al. Retinal nerve fiber layer evaluation by optical coherence tomography in Leber’s hereditary optic neuropathy. Ophthalmology. 2005;112:120–126.

35.Sadun A, Salomao SR, Berezovsky A, et al. Subclinical carriers and conversions in Leber’s hereditary optic neuropathy: a prospective psychophysical study. Trans Am Ophthalmol Soc. 2006;104:51–61.

36.Kjer P. Infantile optic atrophy with dominant mode of inheritance: a clinical and genetic study of 19 Danish families. Acta Ophthalmol. 1959;(Suppl 54):1–147.

37.Kerrison JB. Hereditary optic neuropathies. Ophthalmol Clin North Am. 2001;14: 99–107.

 

 

Inherited or Congenital Optic Nerve Diseases

191

 

38.

Kline LB, Glaser JS. Dominant optic atrophy: the clinical profile. Arch Ophthalmol.

 

 

1979;97:1680–1686.

 

 

39.

Votruba M, Aijaz S, Moore AT. A review of primary hereditary optic neuropathies.

 

 

J Inherit Metab Disord. 2003;26:209–227.

 

 

40.

Kline LB, Siatkovsky RM. Developmental and hereditary optic nerve diseases. In: Kline

 

 

LB, Foroozan R, eds. Optic Nerve Disorders (Ophthalmology Monograms). New York:

 

 

Oxford University Press; 2007:151–170.

 

 

41.

Newman NJ. Hereditary optic neuropathies: from the mitochondria to the optic nerve.

 

42.

Am J Ophthalmol. 2005;140:517–523.

 

,

Hoyt CS. Autosomal dominant optic atrophy: a spectrum of disability. Ophthalmology.

 

 

1980;87:245–251.

 

 

43.

Delettre C, Lenaers G, Griffoin JM, et al. Nuclear gene OPA1, encoding a mitochondrial

 

 

dynamin-related protein, is mutated in dominant optic atrophy. Nat Genet. 2000;26:

 

 

207–210.

 

 

44.

Eiberg H, Kjer B, Kjer P, et al. Dominant optic atrophy (OPA1) mapped to chromosome

 

 

3q region, I: linkage analysis. Hum Mol Genet. 1994;3:977–980.

 

 

45.

Delettre C, Lenaers G, Pelloquin L, et al. OPA 1 dominant optic atrophy: a novel

 

 

mitochondrial disease. Mol Genet Metab. 2002;75:97–107.

 

 

46.

Pesch UE, Fries JE, Bette S, et al. OPA1, the disease gene for autosomal dominant optic

 

 

atrophy, is specially expressed in ganglion cells and intrinsic neurons of the retina.

 

 

Invest Ophthalmol Vis Sci. 2004;45:4217–4221.

 

 

47.

Johnston PB, Gaster RN, Smith VC, et al. A clinic pathologic study of autosomal

 

 

dominant optic atrophy. Am J Ophthalmol. 1979;88:868–875.

 

 

48.

Waardenburg PJ. Different types of hereditary optic atrophy. Acta Genet. 1957;7:

 

 

287–290.

 

 

49.

Newman NJ. Hereditary optic neuropathies. In: Miller NR, Newman NJ, eds. Walsh

 

 

and Hoyt’s Clinical Neuro-Ophthalmology. Baltimore: Williams & Wilkins; 1998:

 

 

742–756.

 

 

50.

Newman NJ, Biousse V. Hereditary optic neuropathies. Eye. 2004;11:1144–1160.

 

,

This page intentionally left blank

6

Acquired Optic Nerve Diseases

CARLOS FILIPE CHICANI, MD, PHD, PETER A. QUIROS, MD, AND ALFREDO A. SADUN, MD, PHD

6-1 INTRODUCTION

This chapter focuses on the most frequently acquired optic nerve diseases: their signs and symptoms, visual field findings, and the required basic workup and management.

Acquired optic nerve diseases are often vision threatening and sometimes even life threatening. There is a need for accurate and timely diagnosis. Therefore, it is incumbent on the clinician to identify optic neuropathies, separate them from chronic congenital and hereditary problems, and aggressively pursue the diagnosis and treatment as necessary. In the workup of optic neuropathies, the visual field is extremely helpful. All patients with suspected optic neuropathies require careful examination of the visual fields for detection, characterization, and monitoring.

Acquired optic neuropathies include inflammatory, ischemic, compressive, metabolic, and central nervous system–reflected pathology (papilledema). Inflammatory optic neuropathies include optic neuritis and its various etiologies such as demyelination, infective, immune-mediated (atypical), and slowly progressive/ chronic. Ischemic optic neuropathies include nonarteritic ischemic optic neuropathy (NAION) and arteritic ischemic optic neuropathy (AAION). Metabolic optic neuropathies include nutritional and/or toxic etiologies. Compressive optic neuropathies can occur due to mass effect on the disc optic, gliomas, and perioptic meningiomas. Papilledema may be primary (pseudotumor cerebri) or secondary to central nervous system mass effect.

193

,

194 Visual Fields

6-2 OPTIC NEURITIS

Optic neuritis is defined as a primary inflammation of the optic nerve. It is characterized by central visual loss that worsens over days and usually peaks about 1 to 2 weeks after the onset. It is usually unilateral but may be bilateral, especially in children, following viral infections like measles, mumps, and chickenpox. It occurs most commonly in adults (18-45 years old). Orbital or periocular pain may be present or precede the visual loss and is exacerbated with eye movements. Etiologies include demyelinating diseases/multiple sclerosis;, idiopathic, viral, or bacterial infections (syphilis); contiguous inflammation of the meninges, orbit, or sinuses,; granulomatous inflammation (tuberculosis, sarcoidosis, and cryptococosis); and autoimmune diseases. It is the most common cause of acute visual loss from optic nerve disease in the young and middle-aged adult group.

There is loss of color vision and perception of light intensity. Relative afferent pupilary defect (RAPD) is seen in unilateral or asymmetric cases. Uhtoff’s phenomena (visual deficit with exercise or increase in body temperature) may occur.

When it occurs in the intraocular portion of the optic nerve is termed papilitis or anterior optic neuritis, and some degree of disc swelling is seen with or without peripapillary hemorrhages. When the intraorbital part of the optic nerve is affected (majority of cases), it is termed retrobulbar or posterior optic neuritis and usually funduscopy is normal.1-4

Visual field findings include the following:

1.Central scotoma. This involves the central 5° to 20° surrounding fixation. Central scotoma usually indicates damage to the macular retinal ganglion cells [RGCs]or to the papillomacular nerve fibers at or within the optic nerve. If the scotoma incorporates the blind spot, the optic nerve is certainly involved.

2.Paracentral scotoma. This involves defects within 20° of the fovea.

3.Diffuse depression. There is generalized decreased visual sensitivity.5-8

Figure 6-1 shows central depression in a patient with optic neuritis.

The asymptomatic fellow eye may show some defect in up to one third of the cases.8

Magnetic resonance imaging (MRI) of the brain should be undertaken to look for signs of optic nerve enhancement (50-80%) and demyelination (up to 30%). An attack of monosymptomatic optic neuritis may precede the development of multiple sclerosis.

The natural history of the disease is for visual function to recover in a few weeks. In cases of profound visual loss or where the need for faster improvement is necessary, treatment with IV steroids is recommended (methylprednisolone 1 g/day for 3 days, followed by prednisone 1 mg/kg/day tapered over 11 days). In cases of positive findings on MRI (three or more T2 hyperintensities), the above protocol should be performed. Based on the Optic Neuritis Treatment Trial, it has been

Acquired Optic Nerve Diseases

195

,

Figure 6-1. Central depression in a patient with optic neuritis.

shown that treatment results in a decrease in conversion to multiple sclerosis over the next 2 years compared with no treatment.9-16

In a minority of cases, the vision may not improve over time or even worsen; these are the atypical or “chronic” cases. Additional workup for autoimmune and infective causes should be performed in these patients.

In children, it is more common to see bilateral cases; disc edema is also more frequent than in the adult population. It usually follows a febrile prodrome, but it has a lower association with future multiple sclerosis.1